Posters

One year outcome and satisfaction of presbyopia correction using the PresbyMAX® monocular ablation profile

Poster Details

First Author: D.Fu CHINA

Co Author(s):    J. Zhao   X. Zhou                 

Abstract Details

Purpose:

To explore the safety, efficacy, and satisfaction of the PresbyMAX monocular mode for the correction of presbyopia.

Setting:

Eye and ENT Hospital of Fudan University

Methods:

Non-randomized, prospective study. Twenty-two patients ( mean age 50.6 ± 6.2 years, 11 myopia patients and 11 hyperopia patients) were enrolled. The dominant eye was fully corrected for distance vision; the non-dominant eye was corrected using central PresbyMAX monocular mode. Binocular uncorrected distance visual acuity (BUDVA), near visual acuity (BUNVA), intermediate visual acuity (BUIVA), corrected distance visual acuity (CDVA), and mean spherical equivalent（SE）were tested at 1 day, 1 week, 1 month, 3 months, and 1 year postoperatively. Questionnaire was performed preoperatively, 1 month, 3months, and 1year after surgery.

Results:

The safety index was 1.03 ± 0.14. There were 85.7% eyes with the same or better CDVA than the preoperative value, and 17.1% and 2.9% eyes gained 1 and 2 lines of CDVA. All treated eyes achieved 20/25 or better BUDVA, and 95.5% achieved 20/32 or better BUNVA, which improved significantly compared with preoperative values (P<0.001). BUDVA maintained stability from 1 month postoperatively, BUNVA and BUIVA kept stable since 1week. Overall satisfaction was 95.5% (21/22) at 3 months visit, and 100% at the last visit. No differences of visual acuity and satisfaction were found between myopia and hyperopia groups.

Conclusions:

The PresbyMAX monocular ablation profile was safe and effective in treating presbyopia, with great satisfaction achieved after postoperative 1 year.

Financial Disclosure:

None